Abstract
New drug approvals reached an all-time high in 2023, with five gene therapies, the first CRISPR–Cas9-edited therapy and a disease-modifying Alzheimer’s drug.
Cite
CITATION STYLE
APA
Senior, M. (2024, March 1). Fresh from the biotech pipeline: record-breaking FDA approvals. Nature Biotechnology. Nature Research. https://doi.org/10.1038/s41587-024-02166-7
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free